Works matching AU Ashton, Nicholas J.
Results: 416
Evaluation of two plasma‐based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14610
- By:
- Publication type:
- Article
Machine learning prediction of tau‐PET in Alzheimer's disease using plasma, MRI, and clinical data.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14600
- By:
- Publication type:
- Article
A head‐to‐head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14609
- By:
- Publication type:
- Article
Predicting survival rate by plasma biomarkers and clinical variables in syndromes associated with frontotemporal lobar degeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14558
- By:
- Publication type:
- Article
Plasma p‐tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10‐year window.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14537
- By:
- Publication type:
- Article
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker‐guided diagnostics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14526
- By:
- Publication type:
- Article
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14508
- By:
- Publication type:
- Article
Clinical utility of plasma p‐tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14502
- By:
- Publication type:
- Article
Plasma p‐tau<sub>217</sub> and neurofilament/p‐tau<sub>217</sub> ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14482
- By:
- Publication type:
- Article
Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 2, p. 1, doi. 10.1002/alz.14434
- By:
- Publication type:
- Article
Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 1, p. 1, doi. 10.1002/alz.14405
- By:
- Publication type:
- Article
Plasma Alzheimer's disease biomarker variability: Amyloid‐independent and amyloid‐dependent factors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 1, p. 1, doi. 10.1002/alz.14368
- By:
- Publication type:
- Article
Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 1, p. 1, doi. 10.1002/alz.14364
- By:
- Publication type:
- Article
The detection of GRN mutation carriers by progranulin blood protein levels from finger‐stick collection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 1, p. 1, doi. 10.1002/alz.14259
- By:
- Publication type:
- Article
Inflammation in the white matter relates to core Alzheimer's disease pathophysiological processes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.094116
- By:
- Publication type:
- Article
Neuroinflammation potentiates the effect of amyloid‐β on longitudinal tau changes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.094105
- By:
- Publication type:
- Article
Hippocampal degeneration is associated with GFAP levels in individuals with vascular dementia independently of amyloidosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.094078
- By:
- Publication type:
- Article
The role of biofluid markers in predicting near‐term cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.094038
- By:
- Publication type:
- Article
Astrocyte reactivity associates with tau phosphorylation and neurodegeneration before detectable amyloid‐β pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.093999
- By:
- Publication type:
- Article
Associations of 18F‐RO‐948 Tau PET with Fluid AD Biomarkers, Centiloid, and Cognition in the Early AD Continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.093976
- By:
- Publication type:
- Article
Longitudinal association between synaptic dysfunction and Alzheimer's disease pathology in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.093923
- By:
- Publication type:
- Article
Plasma and neuroimaging biomarkers of small vessel disease and Alzheimer's disease in a diverse cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.093879
- By:
- Publication type:
- Article
Phosphorylated tau is more closely associated with the spatial extent of tauopathy than with tau load.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.093734
- By:
- Publication type:
- Article
Comparison of amyloid positron emission tomography, hippocampal volume, and plasma biomarkers in predicting conversion to mild cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S9, p. 1, doi. 10.1002/alz.093667
- By:
- Publication type:
- Article
Structural and functional locus coeruleus‐norepinephrine system metrics are distinctly related to affective and stress‐related reports in the context of AD markers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S8, p. 1, doi. 10.1002/alz.095603
- By:
- Publication type:
- Article
Plasma GFAP, cortical amyloid, and cortical tau interact to predict neuroinflammatory changes within Alzheimer's‐relevant white matter bundles.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S8, p. 1, doi. 10.1002/alz.095354
- By:
- Publication type:
- Article
The assessment of synaptic dysfunction in neurodegenerative disorders by a novel single molecular array for Neuronal pentraxin 2.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S8, p. 1, doi. 10.1002/alz.095251
- By:
- Publication type:
- Article
Plasma proteome profile of Lewy body pathology‐positive individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S8, p. 1, doi. 10.1002/alz.095217
- By:
- Publication type:
- Article
Validation of the plasma phosphorylated tau quantified using NUcleic acid Linked Immuno‐Sandwich Assay (NULISA) for the detection of Alzheimer's disease pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S8, p. 1, doi. 10.1002/alz.094671
- By:
- Publication type:
- Article
Is the residual approach reliable to estimate resilience to Alzheimer's disease pathology? Comparison among different methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S7, p. 1, doi. 10.1002/alz.092275
- By:
- Publication type:
- Article
Lower plasma p‐tau levels and larger hippocampi may protect African American SuperAgers from age‐related cognitive decline and Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S7, p. 1, doi. 10.1002/alz.091490
- By:
- Publication type:
- Article
Exploring the utility of Plasma GFAP as a secondary endpoint in Alzheimer's disease Clinical trials to monitor disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.093417
- By:
- Publication type:
- Article
Plasma p‐tau217 outperforms [<sup>18</sup>F]FDG‐PET in identifying biological Alzheimer's disease in atypical and early‐onset dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.093116
- By:
- Publication type:
- Article
Optimizing tau‐PET referrals in memory clinics through a blood biomarker workflow.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.093092
- By:
- Publication type:
- Article
The New Zealand‐Dementia Prevention Research Clinics: Plasma biomarkers and the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.093096
- By:
- Publication type:
- Article
Longitudinal change of cerebral amyloid and tau and its association with plasma biomarkers in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.093070
- By:
- Publication type:
- Article
Inflammation in the white matter relates to core Alzheimer's disease pathophysiological processes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.093072
- By:
- Publication type:
- Article
Inflammation links in Alzheimer's Disease: connecting fluid proteomics and TSPO PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092999
- By:
- Publication type:
- Article
Neuroinflammation potentiates the effect of amyloid‐β on longitudinal tau changes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092935
- By:
- Publication type:
- Article
Neighborhood disadvantage and ADRD pathology assessed with plasma biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092869
- By:
- Publication type:
- Article
Assessing the feasibility of dried blood spot (DBS) collection for blood‐based biomarkers of Alzheimer's Disease in rural South Africa.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092596
- By:
- Publication type:
- Article
Plasma GFAP use for population enrichment of clinical trials in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092554
- By:
- Publication type:
- Article
Plasma proteomic profiling of mild cognitive impairment in two cohorts using the NULISAseq CNS Disease panel.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092364
- By:
- Publication type:
- Article
Associations between neuropsychological tests, plasma biomarkers and PET amyloid scans in a memory clinic cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092323
- By:
- Publication type:
- Article
Plasma proteomic changes in carriers of progranulin mutations on the novel NULISA platform.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092348
- By:
- Publication type:
- Article
The role of biofluid markers in predicting near‐term cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092241
- By:
- Publication type:
- Article
CSF profiling of impaired Blood‐brain barrier individuals: novel putative biomarkers discovery.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092219
- By:
- Publication type:
- Article
Longitudinal plasma and CSF analyses in Down syndrome. Results from the DABNI cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092030
- By:
- Publication type:
- Article
Astrocyte reactivity associates with tau phosphorylation and neurodegeneration before detectable amyloid‐β pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.091735
- By:
- Publication type:
- Article
Determining APOE ε4 carriership by NUcleic acid Linked Immuno‐Sandwich Assay (NULISA).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.091535
- By:
- Publication type:
- Article